
New Leaf Venture Partners
30 portfolio companies · 5 on the map · $1.1B raised · 5 cities
Portfolio map
5 New Leaf Venture Partners portfolio companies on the map.
Portfolio companies

CRISPR Therapeutics
Boston
CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.
Biotechnology Research$957MEst. 2013
Arine
San Francisco
Arine is the leading AI-powered medication optimization platform that improves patient outcomes and reduces healthcare costs by ensuring that patients receive the most effective and appropriate medications. By integrating advanced analytics with deep clinical expertise, Arine provides timely, personalized recommendations, enabling health plans and risk-based provider organizations to enhance medication safety, adherence, and effectiveness among their members.
Hospitals and Health Care$70M
Bluesight
Alexandria
Bluesight is a medication intelligence company that utilizes AI and machine learning to reduce risks and solve supply chain inefficiencies.
Software Development$49.9MEst. 2011BrightInsight
San Jose
BrightInsight offers a global regulated digital health platform for biopharma and medtech.
IT Services and IT Consulting$13MEst. 2017
Principia Biopharma
South San Francisco
Sanofi is a global biopharma company focused on prescription drugs, vaccines, and treatments for chronic, rare, and infectious diseases.
BiotechnologyPublicEst. 2008Hiring fast
More portfolio companies
25 more New Leaf Venture Partners investments we track beyond the map.
TigerConnectSanta Monica · Series D
CareDxBrisbane · Series G
Qlaris BioWellesley · Series B
RallybioFarmington · Series B
AbcuroNewton · Series C
TruverisNew York · Series E
Sunbird BioSingapore · Venture
Deciphera PharmaceuticalsWaltham · Series C
AVEO OncologyCambridge · Post-IPO Equity
iRhythm TechnologiesSan Francisco · Series D
BraeburnPlymouth Meeting · Debt Financing
NeuroneticsMalvern · Series G
Iterum TherapeuticsDublin · Series B
Passage BioPhiladelphia · Series B
ChimerixDurham · Series F
ObsEvaPlan-les-ouates · Post-IPO Equity
Technology Will Save UsLondon · Series A
Oxford ImmunotecAbingdon · Venture
Kyruus HealthBoston · Series C
Cerexa Inc.New York · Series A
IlluminOss MedicalEast Providence · Series C
VisiogenIrvine · Series E
Synageva BioPharmaWaltham · Venture
WorldHeartSalt Lake City · Venture
Transcept PharmaceuticalsRichmond · Series D
Portfolio map
5 New Leaf Venture Partners portfolio companies on the map.